.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Federal Trade Commission
Deloitte
Cipla
Dow
Mallinckrodt
Medtronic
Merck
Chinese Patent Office
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

CHILDREN'S MOTRIN COLD Drug Profile

« Back to Dashboard

Which patents cover Children's Motrin Cold, and when can generic versions of Children's Motrin Cold launch?

Children's Motrin Cold is a drug marketed by J And J Consumer Inc and is included in one NDA. There is one patent protecting this drug.

This drug has fourteen patent family members in thirteen countries.

The generic ingredient in CHILDREN'S MOTRIN COLD is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

Summary for CHILDREN'S MOTRIN COLD

Drug patent expirations by year for CHILDREN'S MOTRIN COLD

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
J And J Consumer IncCHILDREN'S MOTRIN COLDibuprofen; pseudoephedrine hydrochlorideSUSPENSION;ORAL021128-001Aug 1, 2000OTCYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: CHILDREN'S MOTRIN COLD

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,060,730Rapidly absorbed liquid compositions► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CHILDREN'S MOTRIN COLD

Country Document Number Estimated Expiration
China1277841► Subscribe
Australia3794300► Subscribe
Brazil0002607► Subscribe
South Korea20010007332► Subscribe
Japan2001019638► Subscribe
South Africa200002892► Subscribe
Argentina024314► Subscribe
New Zealand504944► Subscribe
Canada2311039► Subscribe
European Patent Office1059084► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Julphar
Daiichi Sankyo
Novartis
Cipla
Merck
Cerilliant
Harvard Business School
Mallinckrodt
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot